A 104-week, multicenter, single-arm, long-term, phase 3 extension trial investigating the safety and efficacy of Glepaglutide in adult patients with short bowel syndrome (SBS) completing the EASE SBS 2 trial

13785EASESBS3EXT-NCT04991311Open (affiliates only)A 104-week, multicenter, single-arm, long-term, phase 3 extension trial investigating the safety and efficacy of Glepaglutide in adult patients with short bowel syndrome (SBS) completing the EASE SBS 2 trial ZP1848-20110NCT04991311IndustrialAdultTreatmentIIIDiseases Of The Digestive SystemSubramanian, SukanyaGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Transplant; GUMC Transplant - Intestines (Small Bowel)2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>